Cell Mol Life Sci. 2011 Feb;68(4):635-49. Epub 2010 Oct 26.

Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Malgrange B, Borgs L, Grobarczyk B, Purnelle A, Ernst P, Moonen G, Nguyen L.

Source

GIGA-Neurosciences, University of Liege, Liege, Belgium. bmalgrange@ulg.ac.be

Abstract

Human pluripotent stem cells, including embryonic (hES) and induced pluripotent stem cells (hiPS), retain the ability to self-renew indefinitely, while maintaining the capacity to differentiate into all cell types of the nervous system. While human pluripotent cell-based therapies are unlikely to arise soon, these cells can currently be used as an inexhaustible source of committed neurons to perform high-throughput screening and safety testing of new candidate drugs. Here, we describe critically the available methods and molecular factors that are used to direct the differentiation of hES or hiPS into specific neurons. In addition, we discuss how the availability of patient-specific hiPS offers a unique opportunity to model inheritable neurodegenerative diseases and untangle their pathological mechanisms, or to validate drugs that would prevent the onset or the progression of these neurological disorders.

PMID:: 20976521; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Degenerative Nerve Diseases - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. [Neurogenetics. 2008]
Review Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders.
Chamberlain SJ, Li XJ, Lalande M. Neurogenetics. 2008 Oct; 9(4):227-35. Epub 2008 Sep 13.
Review Cardiac applications for human pluripotent stem cells. [Curr Pharm Des. 2009]
Review Cardiac applications for human pluripotent stem cells.
Shiba Y, Hauch KD, Laflamme MA. Curr Pharm Des. 2009; 15(24):2791-806.
In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocol. [Methods Mol Biol. 2010]
In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocol.
Ozolek JA, Jane EP, Esplen JE, Petrosko P, Wehn AK, Erb TM, Mucko SE, Cote LC, Sammak PJ. Methods Mol Biol. 2010; 584:71-95.
What can pluripotent stem cells teach us about neurodegenerative diseases? [Nat Neurosci. 2010]
What can pluripotent stem cells teach us about neurodegenerative diseases?
Wichterle H, Przedborski S. Nat Neurosci. 2010 Jul; 13(7):800-4.
Review Differentiation of neural lineage cells from human pluripotent stem cells. [Methods. 2008]
Review Differentiation of neural lineage cells from human pluripotent stem cells.
Schwartz PH, Brick DJ, Stover AE, Loring JF, Müller FJ. Methods. 2008 Jun; 45(2):142-58. Epub 2008 May 29.

See reviews... See all...

Cited by 2 PubMed Central articles

Kinesin light chain 1 suppression impairs human embryonic stem cell neural differentiation and amyloid precursor protein metabolism. [PLoS One. 2012]
Kinesin light chain 1 suppression impairs human embryonic stem cell neural differentiation and amyloid precursor protein metabolism.
Killian RL, Flippin JD, Herrera CM, Almenar-Queralt A, Goldstein LS. PLoS One. 2012; 7(1):e29755. Epub 2012 Jan 17.
Patient-specific pluripotent stem cells in neurological diseases. [Stem Cells Int. 2011]
Patient-specific pluripotent stem cells in neurological diseases.
Durnaoglu S, Genc S, Genc K. Stem Cells Int. 2011; 2011:212487. Epub 2011 Jul 3.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Using human pluripotent stem cells to untangle neurodegenerative disease mechani...
Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.
Cell Mol Life Sci. 2011 Feb ;68(4):635-49. Epub 2010 Oct 26 .

PubMed
Host genetics and HIV-1: the final phase?
Host genetics and HIV-1: the final phase?
PLoS Pathog. 2010 Oct 14 ;6(10):e1001033.

PubMed
Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: usin...
Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model.
PLoS One. 2010 Oct 15 ;5(10):e13392.

PubMed
Reversible block of mouse neural stem cell differentiation in the absence of dic...
Reversible block of mouse neural stem cell differentiation in the absence of dicer and microRNAs.
PLoS One. 2010 Oct 18 ;5(10):e13453.

PubMed
Human milk protein production in xenografts of genetically engineered bovine mam...
Human milk protein production in xenografts of genetically engineered bovine mammary epithelial stem cells.
PLoS One. 2010 Oct 19 ;5(10):e13372.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: